DNA replicative functions of highly-expressed, codon-optimized human papillomavirus proteins E1 and E2WANG, Xin-Min; JANSEN, Kathrin U; MCCLEMENTS, William L et al.Journal of virological methods. 2003, Vol 108, Num 1, pp 83-90, issn 0166-0934, 8 p.Article

Vaccine Technology III: Advances in Vaccine TechnologyWEINER, David B; BUCKLAND, Barry; JANSEN, Kathrin U et al.Vaccine. 2011, Vol 29, Num 41, issn 0264-410X, 106 p.Conference Proceedings

Vaccine review: Staphyloccocus aureus vaccines: Problems and prospectsJANSEN, Kathrin U; GIRGENTI, Douglas Q; SCULLY, Ingrid L et al.Vaccine. 2013, Vol 31, Num 25, pp 2723-2730, issn 0264-410X, 8 p.Article

Preservative of choice for Prev(e)nar 13^™ in a multi-dose formulationKHANDKE, Lakshmi; YANG, Cindy; KRYLOVA, Ksenia et al.Vaccine. 2011, Vol 29, Num 41, pp 7144-7153, issn 0264-410X, 10 p.Conference Paper

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7ACOOPER, David; XINHONG YU; SIDHU, Mohinder et al.Vaccine. 2011, Vol 29, Num 41, pp 7207-7211, issn 0264-410X, 5 p.Conference Paper

Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of ageGREENBERG, Richard N; GURTMAN, Alejandra; FRENCK, Robert W et al.Vaccine. 2014, Vol 32, Num 20, pp 2364-2374, issn 0264-410X, 11 p.Article

A Multi-country Evaluation of Neisseria meningitidis Serogroup B Factor H―Binding Proteins and Implications for Vaccine Coverage in Different Age GroupsHOISETH, Susan K; MURPHY, Ellen; TAHA, Muhamed-Kheir et al.The Pediatric infectious disease journal. 2013, Vol 32, Num 10, pp 1096-1101, issn 0891-3668, 6 p.Article

A Randomized, Controlled, Phase 1/2 Trial of a Neisseria meningitidis Serogroup B Bivalent rLP2086 Vaccine in Healthy Children and AdolescentsNISSEN, Michael D; MARSHALL, Helen S; RICHMOND, Peter C et al.The Pediatric infectious disease journal. 2013, Vol 32, Num 4, pp 364-371, issn 0891-3668, 8 p.Article

Enhancing the role of veterinary vaccines reducing zoonotic diseases of humans: Linking systems biology with vaccine developmentGARRY ADAMS, L; KHARE, Sangeeta; LAWHON, Sara D et al.Vaccine. 2011, Vol 29, Num 41, pp 7197-7206, issn 0264-410X, 10 p.Conference Paper

Foot and mouth disease (FMD) virus: Quantification of whole virus particles during the vaccine manufacturing process by size exclusion chromatographySPITTELER, Marcelo A; FERNANDEZ, Ignacio; SCHABES, Erika et al.Vaccine. 2011, Vol 29, Num 41, pp 7182-7187, issn 0264-410X, 6 p.Conference Paper

Detection of specific human papillomavirus types in paraffin-embedded sections of cervical carcinomasBRYAN, Janine T; TADDEO, Frank; SKULSKY, Deemarie et al.Journal of medical virology. 2006, Vol 78, Num 1, pp 117-124, issn 0146-6615, 8 p.Article

Immunogenicity and reactogenicity of a novel vaccine for human papillomavirus 16 : A 2-year randomized controlled clinical trialPOLAND, Gregory A; JACOBSON, Robert M; KOUTSKY, Laura A et al.Mayo Clinic proceedings. 2005, Vol 80, Num 5, pp 601-610, issn 0025-6196, 10 p.Article

Poor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in menFIFE, Kenneth H; COPLAN, Paul M; JANSEN, Kathrin U et al.Sexually transmitted diseases. 2003, Vol 30, Num 3, pp 246-248, issn 0148-5717, 3 p.Article

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trialRICHMOND, Peter C; MARSHALL, Helen S; EIDEN, Joseph et al.Lancet. Infectious diseases (print). 2012, Vol 12, Num 8, pp 597-607, issn 1473-3099, 11 p.Article

Ensuring the safety of vaccine cell substrates by massively parallel sequencing of the transcriptomeONIONS, D; COTE, C; LOVE, B et al.Vaccine. 2011, Vol 29, Num 41, pp 7117-7121, issn 0264-410X, 5 p.Conference Paper

Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal diseaseJIANG, Han-Qing; HOISETH, Susan K; DASILVA, Ida et al.Vaccine. 2010, Vol 28, Num 37, pp 6086-6093, issn 0264-410X, 8 p.Article

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in GermanyKIENINGER, Dorothee M; KUEPER, Kathrin; SCOTT, Daniel A et al.Vaccine. 2010, Vol 28, Num 25, pp 4192-4203, issn 0264-410X, 12 p.Article

A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infectionHEPLER, Robert W; KELLY, Rosemarie; GINA ZANG et al.Vaccine. 2006, Vol 24, Num 10, pp 1501-1514, issn 0264-410X, 14 p.Article

A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccineAULT, Kevin A; GIULIANO, Anna R; BARR, Eliav et al.Vaccine. 2004, Vol 22, Num 23-24, pp 3004-3007, issn 0264-410X, 4 p.Article

Nonreplicating Vaccines Can Protect African Green Monkeys From the Memphis 37 Strain of Respiratory Syncytial VirusEYLES, Jim E; JOHNSON, J. Erik; KOTASH, Cheryl S et al.The Journal of infectious diseases. 2013, Vol 208, Num 2, pp 319-329, issn 0022-1899, 11 p.Article

Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United StatesXIN WANG; COHN, Amanda; PIZZA, Mariagrazia et al.Vaccine. 2011, Vol 29, Num 29-30, pp 4739-4744, issn 0264-410X, 6 p.Article

Statistical optimization of influenza H1N1 production from batch cultures of suspension Vero cells (sVero)PAILLET, Cristian; FORNO, Guillermina; SOLDANO, Nicolas et al.Vaccine. 2011, Vol 29, Num 41, pp 7212-7217, issn 0264-410X, 6 p.Conference Paper

Vaccine stabilization: Research, commercialization, and potential impactKRISTENSEN, Debra; CHEN, Dexiang; CUMMINGS, Ray et al.Vaccine. 2011, Vol 29, Num 41, pp 7122-7124, issn 0264-410X, 3 p.Conference Paper

Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup B Neisseria meningitidisMURPHY, Ellen; ANDREW, Lubomira; DEGHMANE, Ala-Eddine et al.The Journal of infectious diseases. 2009, Vol 200, Num 3, pp 379-389, issn 0022-1899, 11 p.Article

A methodological approach to scaling up fermentation and primary recovery processes to the manufacturing scale for vaccine productionLEE, Timothy S.Vaccine. 2009, Vol 27, Num 46, pp 6439-6443, issn 0264-410X, 5 p.Conference Paper